Emergency physicians' knowledge of cannabinoid designer drugs

Western Journal of Emergency Medicine

Volumn 14, Issue 5, 2013, Pages 467-470

  Lank, Patrick M ^a   Pines, Elizabeth ^a   Mycyk, Mark B ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Emergency medicine; K2; Medical education; Physician knowledge; Spice; Synthetic cannabinoids; Toxicology

Indexed keywords

CANNABIS; COCAINE; DESIGNER DRUG; DIAZEPAM;

ADULT; ARTICLE; EMERGENCY PHYSICIAN; EMERGENCY WARD; HUMAN; INTOXICATION; MEDICAL EDUCATION; NORMAL HUMAN;

EID: 84888131587     PISSN: 1936900X     EISSN: 19369018     Source Type: Journal    
DOI: 10.5811/westjem.2013.1.14496     Document Type: Article

References (13)

1. Schedules of Controlled Substances: Temporary Placement of Five Synthetic Cannabinoids Into Schedule I [FR Doc No: 11075-11078]. Drug Enforcement Administration (DEA). U.S. Department of Justice. (2011). Available at: http://www.deadiversion.usdoj.gov/fed-regs/rules/2011/fr0301.htm. Accessed August 23, 2012.
2. Forrester MB, Kleinschmidt K, Schwarz E, et al. Synthetic cannabinoid exposures reported to Texas poison centers. J Addict Dis. 2011;30:351-358.
3. Carroll FI, Lewin AH, Mascarella SW, et al. Designer drugs: a medicinal chemistry perspective. Ann N Y Acad Sci. 2012;1248:18-38.
4. Johnston LD, O'Malley PM, Bachman JG, et al. Marijuana use continues to rise among U.S. teens, while alcohol use hits historic lows. University of Michigan News Service: Ann Arbor, MI. 2011. Available at: http://www. monitoringthefuture.org/pressreleases/11drugpr.pdf. Accessed August 23, 2012.
5. Schneir AB, Cullen J, Ly BT. "Spice" girls: synthetic cannabinoid intoxication. J Emerg Med. 2011;40(3):296-269.
6. Vardakou I, Pistos C, Spiliopoulou C. Spice drugs as a new trend: mode of action, identification and legislation. Toxicol Lett. 2010;197:157-162.
7. Lapoint J, James LP, Moran CL, et al. Severe toxicity following synthetic cannabinoid ingestion. Clin Toxicol (Phila). 2011;49:760-4.
8. Mir A, Obafemi A, Young A, et al. Myocardial infarction associated with use of the synthetic cannabinoid K2. Pediatrics. 2011;128:e1622-1627.
9. Schneir AB, Baumbacher T. Convulsions associated with the use of a synthetic cannabinoid product. J Med Toxicol. 2012;8:62-64.
10. Cohen J, Morrison S, Greenberg J, et al. Clinical presentation of intoxication due to synthetic cannabinoids. Pediatrics. 2012;129:e1064-1067.
11. Magill M, Barnett NP, Apodaca TR, et al. The role of marijuana use in brief motivational intervention with young adult drinkers treated in an emergency department. J Stud Alcohol Drugs. 2009;70:409-413.
12. Mycyk MB. Emerging drugs of abuse: what was new yesterday is NEW today. J Med Toxicol. 2012;8:1-2.
13. Bronstein AC, Spyker DA, Cantilena LR, et al. 2010 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila). 2011;49:910-941.